Fiasp® is an injectable prescription mealtime insulin used to help improve blood sugar in adults and children with diabetes.
Fee-asp is the correct pronunciation of Fiasp®.
Fiasp® is a formulation of insulin aspart—the same active ingredient in NovoLog® that is proven to help control blood sugar in adults and children with diabetes at mealtimes. A form of vitamin B3 (niacinamide), which speeds up how fast your body absorbs your Fiasp® dose to keep your insulin level stable, was added to create Fiasp®.
Yes, Fiasp® is indicated for use in children with diabetes to help improve blood sugar.
You can take Fiasp® at the start of the meal or 20 minutes after starting a meal. NovoLog® is taken 5 to 10 minutes before a meal.
Your health care provider will let you know which time is right for you to take your insulin. Do not make any changes to your dose or the type of insulin you use unless you are told to do so by your health care provider.
Fiasp® is taken by injection at the start of the meal or 20 minutes after starting a meal. Your health care provider will tell you how to take Fiasp® based on your individual needs. If you think you need to adjust your insulin dose because of illness, new medicine, stress, change in diet, or change in activity level, make sure to talk to your health care provider.
Do not make any changes to your dose or the type of insulin you use unless you are told to do so by your health care provider.
The most common side effect of Fiasp® is low blood sugar. Some signs and symptoms of low blood sugar include anxiety, irritability, mood changes, dizziness, sweating, confusion, and headache. Severe low blood sugar can be life-threatening. For a list of possible side effects, please see the full Important Safety Information.
Do not drive or operate heavy machinery until you know how Fiasp® affects you. Do not drink alcohol or use prescription or over-the-counter medicines that contain alcohol.
Talk to your health care provider about possible side effects.
Serious side effects can lead to death, including:
Your insulin dose may need to change because of:
Common side effects of Fiasp® may include:
Fiasp® comes in:
aRefer to the insulin infusion pump user manual to see if Fiasp® can be used. Use in accordance with the insulin pump’s instructions for use.
bNeedles are sold separately, will need a prescription, and need to be processed by a pharmacist.
Fiasp® FlexTouch® is the latest prefilled insulin device from Novo Nordisk. The Fiasp® FlexTouch® pen has been designed with no push-button extension and offers a click that you may hear or feel when your dose is delivered.c
cAfter dose counter has returned to 0, keep needle in skin for 6 seconds before the needle is removed. If you do not, you may not have received your full dose and you should check your blood sugar levels more often because you may need more insulin. You may or may not hear an audible click at end of dose.
While you don’t need to use a new pen for every dose, you should always use a new needle to help ensure sterility and prevent blocked needles. Do not store the pen with the needle attached. Storing without the needle attached helps prevent leaking, blocking of the needle, and air from entering the pen. Do not share your pen with other people even if the needle has been changed. You may give other people a serious infection or get a serious infection from them. See the full Instructions For Use.
If you select the wrong dose, you can turn the dose selector forward or backward to the correct dose.
Fiasp® pens are designed to work with all Novo Nordisk needles—NovoFine® Autocover®, NovoFine® Plus, and NovoFine®.
Unopened pens, PenFill® cartridges, and vials that have been refrigerated (36°F to 46°F [2°C to 8°C]) can be kept until expiration date.
Unopened pens, PenFill® cartridges, and vials at room temperature (below 86°F [30°C]) can be kept for 28 days.
Opened pens and vials that have been kept at room temperature or refrigerated will last for 28 days.d
dPenFill® cartridges in use (opened) must NOT be stored in the refrigerator.
Do not recap the needle. Recapping can lead to a needle stick injury. Remove the needle from the Fiasp® FlexTouch® after each injection and dispose of it in an FDA-cleared sharps container. Storing the pen without the needle attached helps prevent leaking, blocking of the needle, and air from entering the pen.
If you do not have a sharps container, carefully slip the needle into the outer needle cap. Safely remove the needle and throw it away as soon as you can.
Put used Fiasp® FlexTouch®, PenFill® cartridges, and needles in an FDA-cleared sharps disposal container immediately after use.
Do not throw away (dispose of) loose needles, pens, or PenFill® cartridges in your household trash.
If you do not have an FDA-cleared sharps disposal container, you may use a household container made of heavy-duty plastic (like a detergent bottle).
The Fiasp® FlexTouch® has a red push button and cartridge to differentiate it from other FlexTouch® pens. Always check the insulin label before each injection to avoid accidental mix-ups between different insulin products.
Yes, Fiasp® is approved for use in a pump for adults and children with diabetes.
Fiasp® is approved to be used in a pump! An insulin pump is a small, programmable, battery-operated device that delivers a steady, measured amount of insulin under your skin.
Fiasp® in an insulin pump offers:
The pump releases a steady dose of Fiasp® throughout the day and mealtime doses when you eat. You just program the pump, following your doctor's and the pump maker’s instructions. See the Prescribing Information for instructions on how to use Fiasp® in an insulin pump.
Fiasp® should not be mixed with other insulins when it is used in the pump. Fiasp® should not be kept in the pump for more than 6 days of use, nor should it be in temperatures higher than 98.6°F (37°C). The infusion set and the infusion set insertion site should be changed at least every 3 days.
Omnipod DASH® is cleared for use with Fiasp®. Get more information about the Omnipod DASH® Insulin Management System at MyOmnipod.com.e
eRefer to the insulin infusion pump user manual to see if Fiasp® can be used. Use in accordance with the insulin pump’s instructions for use.
Yes. The Fiasp® PenFill® cartridge can be used in compatible insulin delivery devices (eg, durable pens, such as NovoPen Echo®).
Follow us on Facebook, where we share news and information about Fiasp® and the condition it treats. However, social media isn’t a place for us to provide health care advice. If you have questions about your health or Fiasp®, please talk to your health care provider.
NovoCare® offers bite-sized, everyday lessons on eating better, moving more, and treating diabetes that you can learn in 5 minutes or less. Sign up to receive emails with tips for leading a healthier life and updates about Fiasp®.
Sign up and save on your NovoPen Echo® at NovoCare.com or by calling 1-888-910-1269.g Eligible commercially insured patients may pay as little as $0 for each device (maximum savings of $54 per device).